Pridopidine in Amyotrophic Lateral Sclerosis

Overview of attention for article published in JAMA: Journal of the American Medical Association, February 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 32 news outlets
blogs: 3 blogs
twitter: 10 X users
facebook: 3 Facebook pages

reddit: 1 Redditor
video: 1 YouTube creator
bluesky: 4 Bluesky users
podcasts: 2 podcasts

Readers on

mendeley: 26 Mendeley

So far, Altmetric has seen 11 X posts from 10 X users, with an upper bound of 596,390 followers.

Pridopidine in ALS https://t.co/tqTNXlfaDe Neurodegenerative diseases will never have a good drug in my life. ALS has been known for 100 years & it has zero good drugs. Alzheimer's doesn't have any good drugs either. Why can't scientist beat these…

https://t.co/sWJFVhI6dA

RT @JAMA_current: Pridopidine did not impact the progression of amyotrophic lateral sclerosis in this 24-week study. https://t.co/DWLHEPIsIA

Pridopidine did not impact the progression of amyotrophic lateral sclerosis in this 24-week study. https://t.co/DWLHEPIsIA

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 7 additional X posts.